002940.SZ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 geg. 2024 @ 10:04):

Zhejiang Anglikang Pharmaceutical Co., Ltd. engages in the production and sale of pharmaceutical materials, pharmaceutic preparations, and medical empty capsules...

Stats
Dzisiejszy wolumen	7.53M
Średni wolumen	1.60M
Kapitalizacja rynkowa	3.71B
EPS	CNY0 ( 2023-10-27 )
Następna data zysków	( CNY0 ) 2024-05-15
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	31.00
ATR14	CNY0.0720 (0.39%)

Wolumen Korelacja

Długi: 0.03 (neutral)

Krótki: 0.25 (neutral)

Signal:(51.379) Neutral

Zhejiang AngLiKang Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Zhejiang AngLiKang Korelacja - Waluta/Towar

0.35
( neutral )

-0.20
( neutral )

0.00
( neutral )

-0.72
( moderate negative )

0.04
( neutral )

-0.13
( neutral )

Zhejiang AngLiKang Finanse

Annual	2023
Przychody:	CNY1.63B
Zysk brutto:	CNY725.36M (44.61 %)
EPS:	CNY0.690

FY	2023
Przychody:	CNY1.63B
Zysk brutto:	CNY725.36M (44.61 %)
EPS:	CNY0.690

FY	2022
Przychody:	CNY1.57B
Zysk brutto:	CNY897.89M (57.25 %)
EPS:	CNY0.640

FY	2021
Przychody:	CNY1.38B
Zysk brutto:	CNY892.62M (64.66 %)
EPS:	CNY1.270

Financial Reports:

No articles found.

Zhejiang AngLiKang

Zhejiang Anglikang Pharmaceutical Co., Ltd. engages in the production and sale of pharmaceutical materials, pharmaceutic preparations, and medical empty capsules. The company offers products in anti-infection, antihypertensive, digestive system, and respiratory preparation. It is also involved in research and development of drugs for featuring oral cephalosporins, cardiovascular, kidney, and central nervous diseases. The company was founded in 2001 and is based in Shengzhou, China.